دورية أكاديمية
Integrative Medicine for Ovarian Cancer.
| العنوان: | Integrative Medicine for Ovarian Cancer. |
|---|---|
| المؤلفون: | Ben-Arye E; Integrative Oncology Program, The Oncology Service, Lin, Carmel & Zebulun Medical Centers, Clalit Health Services, Haifa, Western Galilee District, Israel. eranben@netvision.net.il.; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel and Clalit Health Services, Haifa, Western Galilee District, Israel. eranben@netvision.net.il., Lavie O; Department of Obstetrics and Gynecology, Gynecologic Oncology Service, Carmel Medical Center, Haifa, Israel., Heyl W; Department of Obstetrics and Gynecology, Cancer Center North Wurttemberg, Ludwigsburg, Germany., Ramondetta L; Department of Gynecologic Oncology and Reproductive Medicine And Department of Palliative, Rehabilitation, & Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Berman T; Department of Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA., Samuels N; Center for Integrative Complementary Medicine, Faculty of Medicine, Shaarei Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. |
| المصدر: | Current oncology reports [Curr Oncol Rep] 2023 Jun; Vol. 25 (6), pp. 559-568. Date of Electronic Publication: 2023 Mar 20. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Philadelphia, PA : Current Science, c1999- |
| مواضيع طبية MeSH: | Integrative Medicine* , Complementary Therapies* , Neoplasms*/therapy , Integrative Oncology* , Ovarian Neoplasms*/therapy, Humans ; Female ; Medical Oncology |
| مستخلص: | Purpose of Review: Integrative oncology (IO) services provide a wide range of complementary medicine therapies, many of which can augment the beneficial effects of conventional supportive and palliative care for patients with ovarian cancer. This study aims to assess the current state of integrative oncology research in ovarian cancer care. Recent Findings: We review the clinical research both supporting the effectiveness of leading IO modalities in ovarian cancer care as well as addressing potential safety-related concerns. There is growing amount of clinical research supporting the use of IO and implementation of integrative gynecological oncology models of care within the conventional supportive cancer care setting. Additional research is still needed in order to create clinical guidelines for IO interventions for the treatment of female patients with ovarian cancer. These guidelines need to address both effectiveness and safety-related issues, providing oncology healthcare professionals with indications for which these patients can be referred to the IO treatment program. (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
| فهرسة مساهمة: | Keywords: Chemotherapy; Gynecologic oncology; Integrative oncology; Ovarian cancer |
| تواريخ الأحداث: | Date Created: 20230320 Date Completed: 20230508 Latest Revision: 20230524 |
| رمز التحديث: | 20230524 |
| DOI: | 10.1007/s11912-023-01359-8 |
| PMID: | 36939963 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1534-6269 |
|---|---|
| DOI: | 10.1007/s11912-023-01359-8 |